Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had a revenue of 1.65B in the quarter ending Sep 30, 2024, with -12.40%. This bring the company's revenue in the last twelve months to 8.04B, Increased -0.72%. In the fiscal year ending Dec 31, 2023, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had annual revenue of 8.22B with -0.33% growth.